Dr. Cecile E. Becker, M.D.
Neurology (Neurology Physician)
- Medicare participating
At a glance
- Medical school
- Rush Medical College of Rush University (2000)
- Years since graduation
- 26
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 593
Licensed in Illinois since 2005, according to the Illinois Department of Financial and Professional Regulation. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2000Medical school: Rush Medical College of Rush University
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
IL license 036-113219 (first issued 2005; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Memorial Medical Center Springfield, IL
- St Johns Hospital Springfield, IL
- Decatur Memorial Hospital Decatur, IL
- Taylorville Memorial Hospital Taylorville, IL
- Carlinville Area Hospital Carlinville, IL
Medical groups
- Springfield Clinic, LLP (687 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 593
- Services billed
- 50,135
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Injection, onabotulinumtoxina, 1 unit | 35,124 | 45 |
| Needle measurement of electrical activity in arm or leg muscles, complete study | 301 | 176 |
| Established patient office or other outpatient visit, 30-39 minutes | 211 | 165 |
| New patient office or other outpatient visit, 45-59 minutes | 196 | 196 |
| Established patient office or other outpatient visit, 20-29 minutes | 107 | 93 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 76 | 22 |
| Nerve conduction, 7-8 studies | 73 | 73 |
| Insertion of needle into vein for collection of blood sample | 72 | 68 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 48 | 17 |
| New patient office or other outpatient visit, 30-44 minutes | 44 | 44 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 17 companies reported 74 payments worth $1,377 in total to this clinician.
| AbbVie Inc. | $639 |
|---|---|
| Genentech USA, Inc. | $164 |
| Lilly USA, LLC | $124 |
| Axsome Therapeutics, Inc. | $71.83 |
| Alexion Pharmaceuticals, Inc. | $56.41 |
| Lundbeck LLC | $54.81 |
| Biogen, Inc. | $43.02 |
| Pfizer Inc. | $38.32 |
| Food and Beverage | $1,377 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $29,232 in research payments for these studies, mostly to the institutions running them.
- Evaluation of the lilly sp-x p-TAU217 assay by measuring changes in the intended patient management between pre-and post-p-TAU217 result: a randomized clinical utility study
Eli Lilly and Company
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.